Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis
- 15 December 2004
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 117 (12), 938-947
- https://doi.org/10.1016/j.amjmed.2004.06.046
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Nephrotoxic Effects in High-Risk Patients Undergoing AngiographyNew England Journal of Medicine, 2003
- Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast doseThe American Journal of Cardiology, 2002
- Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)The American Journal of Cardiology, 2002
- Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by AcetylcysteineNew England Journal of Medicine, 2000
- Contrast NephropathyJournal of the American Society of Nephrology, 2000
- Acute Renal Failure After Coronary InterventionAmerican Journal Of Medicine, 1997
- The Effect of Acute Renal Failure on MortalityJAMA, 1996
- Effects of Saline, Mannitol, and Furosemide on Acute Decreases in Renal Function Induced by Radiocontrast AgentsNew England Journal of Medicine, 1994
- Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.Radiology, 1993
- Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or BothNew England Journal of Medicine, 1989